Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Dry Eye Medication Market Global Briefing 2017

Dry Eye Medication Market Global Briefing 2017

From $1,000.00

Including: Lubricant Treatments (Preservative-Free Drops, ‘Oily’ Tear Eye Drops, And Eye Ointments), Anti-Inflammatory Treatments (Corticosteroid Eye Drops And Ointments, Oral Tetracyclines, And Ciclosporin Eye Drops), And Serum Eye Drops.
Covering: Novartis, Nicox, Allergan Inc., Bridge Pharma Inc., Santen Pharmaceutical Co., Ltd


Clear selection
SKU: 2267. Category: .
Description

Dry Eye Medication Market Global Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global dry eye medication market.

Description

The Dry Eye Medication Market Global Briefing Report from The Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The dry eye medication market is one of the segments in the ophthalmology drugs market, within the pharmaceutical drugs market.

The market characteristics section of the report defines and explains the market.

The market size section gives the dry eye medication market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the dry eye medication market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the dry eye medication market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 2-3 working days of order.

Scope

Markets Covered: Lubricant treatments (preservative-free drops, ‘Oily’ tear eye drops, and eye ointments), Anti-Inflammatory treatments (corticosteroid eye drops and ointments, oral tetracyclines, and ciclosporin eye drops), and Serum eye drops.

Companies Mentioned: Novartis, Nicox, Allergan Inc., Bridge Pharma Inc., Santen Pharmaceutical Co., Ltd.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Market value in $ billions.

Data segmentations: Regional breakdowns, market share of competitors, key sub segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Related Reports:
Antiglaucoma Drugs Market Global Briefing 2017

Table Of Contents
Table Of Contents

1. Introduction
2. Dry Eye Medication Market Characteristics
3. Dry Eye Medication Market Historic Growth
• Drivers Of The Market
• Restraints On The Market
4. Dry Eye Medication Market Forecast Growth
• Drivers Of The Market
• Restraints On The Market
5. Dry Eye Medication Market Geography Split
6. Dry Eye Medication Market As A Proportion of Ophthalmology Drugs Market, 2016, By Region
7. Dry Eye Medication Market As A Proportion of Ophthalmology Drugs Market, 2016, By Country
8. Dry Eye Medication Market Segmentation
9. Dry Eye Medication Competitive Landscape
Novartis
Nicox
Allergan Inc.
Bridge Pharma Inc.
Santen Pharmaceutical Co., Ltd.
10. Key Mergers And Acquisitions In The Dry Eye Medication Market
11. Dry Eye Medication Market Trends And Strategies
Appendix
NAICS Definitions of Industry Covered In This Report
Research Methodology
Methodology
Data
Market Numbers
Competitor Market Share Data
Analysis
Verification Through Expert Interviews
Referencing
Note on Currency Conversions
Abbreviations
Currencies
Research Inquiries
The Business Research Company

List Of Tables
Table 1: Global Dry Eye Medication Market Historic Market Size, 2012 – 2016, $ Billion
Table 2: Global Dry Eye Medication Market Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Dry Eye Medication Market, Split By Region, 2016, $ Billion
Table 4: Dry Eye Medication Market As A Proportion of Ophthalmology Drugs Market, 2016, By Region
Table 5: Dry Eye Medication Market As A Proportion of Ophthalmology Drugs Market, 2016, By Country
Table 6: Global Dry Eye Medication Market, Key Competitor Shares, 2016, Percentage (%)
Table 7: Global Dry Eye Medication Market, Split By Segments, 2016, $ Billion

List Of Figures
Figure 1: Global Dry Eye Medication Market Historic Market Size, 2012 – 2016, $ Billion
Figure 2: Global Dry Eye Medication Market Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Dry Eye Medication Market, Split By Region, 2016, $ Billion
Figure 4: Dry Eye Medication Market As A Proportion of Ophthalmology Drugs Market, 2016, By Region
Figure 5: Dry Eye Medication Market As A Proportion of Ophthalmology Drugs Market, 2020, By Country
Figure 6: Global Dry Eye Medication Market, Key Competitor Shares, 2016, Percentage (%)
Figure 7: Global Dry Eye Medication Market, Split By Segments, 2016, $ Billion
Executive Summary
The dry eye medications market covers medications that treat keratoconjunctivitis sicca, an ocular disorder caused by the lack of tear fluid to lubricate the eyes. These indications include evaporative dry eye disease and aqueous dry eye disease. By therapeutic type, the market is segmented into three segments: lubricant treatments (preservative-free drops, 'Oily' tear eye drops, and eye ointments); anti-inflammatory treatments (corticosteroid eye drops and ointments, oral tetracyclines, and ciclosporin eye drops); and serum eye drops.

The global dry eye medication market was estimated to be around $3.6 billion as of 2016. The global dry eye medication made up around 3.6% of the overall ophthalmology drugs market in 2016. The dry eye medication market was the smallest market in the global ophthalmology drugs market in 2016.

Regulatory Approvals
Continous approvals from regulatory bodies such as FDA in the US and EMA in Europe is one of the major trend in this market. For instance, in July 2016, Shire US Inc. received FDA approval for its Xiidra (lifitegrast) eye drops for its commercialization in the US market. Xiidra (lifitegrast) eye drops are used in the treatment of dry eye disease. Through this approval, Shire US Inc. focuses to strengthen its position in dry eye medication market by lauching its new Xiidra (lifitegrast) eye drops.
Get Customized Report
Please fill in your details. Our team will get back to you